X T L Biopharmaceuticals reported $-812K in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Alaunos Therapeutics USD -952K 60K Jun/2026
Bioline Rx USD -3.57M 569K Jun/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
X T L Biopharmaceuticals USD -812K 48K Dec/2024